TASE analysis project launched in 2016 to increase investor knowledge of TASE's listing technology and life science companies and the company's operating market
US drug maker Mylan has announced its intention to withdraw from the Tel Aviv Stock Exchange (TASE), ending its involvement for the first time since it entered it in November 2015.